Mar 25, 2013 10:08 AM PDT
|
|
AMEX: OPK Stock Quote
| Last Trade: | 6.93 | Day's Range: | 6.84 - 6.96 | |
| Trade Time: | 4:02pm | 52wk Range: | 4.00 - 7.83 | |
| Change: | -0.04 (-0.57%) | Volume: | 661,690 | |
| Prev Close: | 6.97 | Avg Vol (3m): | 1,632,820 | |
| Open: | 6.9598 | Market Cap: | 2.334B | |
| Bid: | N/A x N/A | P/E (ttm): | N/A | |
| Ask: | N/A x N/A | EPS (ttm): | -0.189 | |
| 1y Target Est: | 8.33 | Div & Yield: | 0.00 (N/A) |
AMEX: OPK Overview
Opko Health Inc. is a specialty healthcare company. The Company is focused on the discovery, development and commercialization of pharmaceutical products, vaccines, diagnostic technologies, and imaging systems. Its business consists of the development of a range of pharmaceutical products and diagnostic tests, and the development, commercialization and sale of ophthalmic diagnostic and imaging systems, and instrumentation products, as well as the sale of pharmaceutical products, over-the-counter products and medical devices to government, private and institutional markets in Chile and Mexico. In October 2009, the Company acquired Pharma Genexx, a company engaged in the marketing, sale, and distribution of pharmaceutical products, over-the-counter products and medical devices for government, private and institutional markets in Chile. In February 2010, it completed the acquisition of Pharmacos Exakta.
Do you know of another great research resource for OPK that belongs here? Please let us know and provide the URL.
